Article
Sofosbuvir and daclatasvir combination therapy for current hepatitis C virus genotype 4 achieves SVR: a case report of HCV genotype 4 from the Amazon.
Revista da Sociedade Brasileira de Medicina Tropical - 1 Jan 2000
Tarragô Andréa Monteiro, Pereira Grenda Leite, Victória Flamir da Silva, Marie Adriana Malheiro Alle, Victória Marilú Barbieri
Abstract excerpt
Hepatitis C is a worldwide endemic disease. However, hepatitis C virus genotype 4 (HCV GT-4) has rarely been reported in Brazil. HCV GT-4 demonstrates high sustained virological response (SVR). Here, we report the case of a 62-year-old HCV GT-4 positive woman complaining of a headache, nausea, and arthralgia. The patient was treated according to the protocol for genotype 4 (12 weeks administration of 400mg...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
